Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Mangalam Drugs and Organics Ltd

Pharmaceuticals & Biotechnology | Small Cap

Mangalam Drugs and Organics Ltd Health Insights
Health Score : 4.50Health Score : 4.50

Mangalam Drugs and Organics Ltd, operating within the Healthcare Services industry, showcases a mixed financial performance. The company demonstrates notable strength in solvency and profitability. However, liquidity, efficiency, and coverage ratios reveal potential areas of concern. While the company has experienced a decline in revenue and EPS growth, its operating profit and asset growth show promise. The company's ability to manage its debts is a notable strength, but its ability to meet its short-term obligations needs improvements. Overall, the company's financial health presents a complex picture, requiring further scrutiny to leverage its strengths and address its weaknesses.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Mangalam Drugs and Organics Ltd Health Insights
Health Score : 4.50Health Score : 4.50

Mangalam Drugs and Organics Ltd, operating within the Healthcare Services industry, showcases a mixed financial performance. The company demonstrates notable strength in solvency and profitability. However, liquidity, efficiency, and coverage ratios reveal potential areas of concern. While the company has experienced a decline in revenue and EPS growth, its operating profit and asset growth show promise. The company's ability to manage its debts is a notable strength, but its ability to meet its short-term obligations needs improvements. Overall, the company's financial health presents a complex picture, requiring further scrutiny to leverage its strengths and address its weaknesses.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

-1.08

Highly Undervalued

Industry Median

18.24

Highly Undervalued
Highly Undervalued

Small Cap Median

12.96

Highly Undervalued

P/E RATIO

-1.07

P/B RATIO

0.46

Highly Undervalued

Industry Median

1.32

Highly Undervalued
Highly Undervalued

Small Cap Median

1.21

Highly Undervalued

P/S RATIO

0.20

Highly Undervalued

Industry Median

1.16

Highly Undervalued
Highly Undervalued

Small Cap Median

1.00

Highly Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Highly Undervalued

EV/EBITDA RATIO

-3.76

Highly Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹30.03 as on Jun 20, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 4.00

The company's growth performance is mixed, showing strength in operating profit and asset growth. However, it has experienced declines in revenue, EPS, and net income growth. While operating profitability and asset expansion are positive signs, the negative trends in revenue and earnings raise concerns about the company's overall growth trajectory. Addressing these factors will be crucial for sustainable long-term growth.

PoorRevenue Growth RatePoor
ExcellentOperating Profit Growth RateExcellent
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2024Mar 2025Mar 2026
Revenue Growth Rate-13.82-27.04
Operating Profit Growth Rate111.76-141.67
Earnings Per Share (EPS) Growth-174.17-760
Asset Growth Rate9.58-13.93
Net Income Growth Rate-177.78-728.57
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.40

The company's financial ratios present a mixed picture. Adjusted EPS, cash EPS, book value per share, dividend per share and capital expenditures are below the expected ranges. The ratios indicate potential areas of concern regarding earnings quality, shareholder value, and investment in future growth. Addressing these issues could improve investor confidence and overall financial health.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)-5.624.38-27.5
Cash Earnings Per Share (Cash EPS)3.7515-16.25
Book Value Per Share8593.1264.38
Dividend Per Share (DPS)000
Capital Expenditures (CapEx)11.819.511.7
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.60

The company demonstrates good profitability, with robust gross profit margin, ROCE, ROE, ROA, operating margin, and net margin. The company is generating profits from its capital employed, equity, and assets. Strong profitability indicates efficient operations and effective cost management. This positions the company favorably within its industry.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
AverageReturn on Assets (ROA)Average
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2024Mar 2025Mar 2026
Gross Profit Margin0.545.97-14.22
Return on Capital Employed (ROCE)1.798-14
Return on Equity (ROE)-6.624.7-42.72
Return on Assets (ROA)5.099.84-4.76
Operating Margin4.6111.32-6.47
Net Margin-2.442.2-18.97
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.33

The company's efficiency in managing its assets presents a mixed picture. It shows strength in receivables turnover. However, fixed asset turnover, inventory turnover, days sales in inventory, and capital turnover are areas needing improvement. While efficient in collecting receivables, the company struggles with asset utilization and inventory management. Improving these areas could significantly enhance operational performance and profitability.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
ExcellentReceivables Turnover RatioExcellent
PoorDays Sales in Inventory RatioPoor
GoodReceivable DaysGood
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.491.951.46
Inventory Turnover Ratio2.952.272.19
Receivables Turnover Ratio13.049.495.87
Days Sales in Inventory Ratio123.73160.79166.67
Receivable Days2838.4662.18
Capital Turnover Ratio2.21.842.05
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 2.00

The company's coverage ratios are weak, particularly concerning interest coverage and equity dividend coverage. The company's ability to cover its interest expenses is limited. With low coverage ratios, the company may face increased financial risk and reduced flexibility in managing its debt and dividend obligations.

PoorInterest Coverage RatioPoor
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2024Mar 2025Mar 2026
Interest Coverage Ratio0.211.33-2.06
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 9.50

The company exhibits good solvency, demonstrating a strong capacity to meet its long-term obligations. Low debt and high equity levels suggest a stable financial structure. The debt-to-asset ratio further supports this, indicating a conservative approach to leveraging assets. This financial stability provides a solid foundation for future growth and resilience against economic downturns.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
GoodEquity RatioGood
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2024Mar 2025Mar 2026
Debt Ratio0.190.140.09
Debt to Equity Ratio0.230.160.1
Equity Ratio0.810.860.91
Debt To Asset Ratio0.10.070.03
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.40

The company's liquidity position is weak, indicating potential difficulties in meeting short-term obligations. The current, quick, and cash ratios are all at concerning levels. The operating cash flow ratio offers a slight positive outlook, suggesting some ability to generate cash from operations. However, the overall low liquidity scores signal a need for improved working capital management to ensure the company can comfortably cover its immediate liabilities.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2024Mar 2025Mar 2026
Current Ratio1.071.040.78
Quick Ratio0.330.320.26
Cash Ratio0.010.020
Operating Cash Flow Ratio0.020.220.02
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 7 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Medicamen Organics Ltd6.30-6.94Neutral-3.75-2.50-4.02
2Mono Pharmacare Ltd6.166.26Neutral8.001.753.00
3JFL Life Sciences Ltd6.079.43Neutral12.001.946.00
4Walpar Nutritions Ltd5.299.26Neutral6.662.093.00
5Mangalam Drugs and Organics Ltd4.50-1.07Neutral-15.00-27.68-44.00
6Lasa Supergenerics Ltd4.39-2.61Highly Undervalued-7.00-6.80-34.00
7Sunrest Lifescience Ltd4.177.06Highly Undervalued10.213.608.00
Management Assessment Summary
OrangeBalanced Management

The management effectiveness of Mangalam Drugs and Organics Ltd is mixed. The company shows operating profit margin (OPM) improvement and net profit turnaround. Declining sales growth and negative Return on Equity pose concerns. Stable promoter holding indicates confidence, but low institutional interest suggests limited external validation. Overall, management is showing improvement signs but needs to address growth challenges and manage debt levels.

Category Metric Value Assessment
PROS Improved Profitability 11% OPM in Mar 2025 Improving operational efficiency
Stable Promoter Holding 50.30% Consistent promoter confidence
CONS Declining Sales Growth -13.66% Decreasing revenue expansion
Low Return on Equity -6.15 Poor shareholder returns
AverageFinancial Performance & GrowthAverage
WeakCapital Efficiency & ReturnsWeak
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Mangalam Drugs and Organics Ltd faces moderate risk due to segment performance volatility, declining sales, and negative Return on Equity (ROE). The increase in inventory days and cash conversion cycle indicates operational inefficiencies, and the high level of borrowings raises concerns about financial leverage.

AverageSegment performance volatilityAverage
01.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1029.97Bullish
  3. SMA 2030.03Bullish
  4. SMA 5029.37Bullish
  5. EMA 1029.93Bullish
  6. EMA 2029.89Bullish
  7. EMA 5029.55Bullish
  8. DEMA 1029.90Bullish
  9. DEMA 2030.06Bullish
  10. DEMA 5030.01Bullish
  11. TEMA 1029.86Bullish
  12. TEMA 2029.92Bullish
  13. TEMA 5030.29Bearish
  14. MACD0.10Bearish
  15. ADX20.84Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI55.48Neutral
  3. CCI-11.18Neutral
  4. ROC 90.03Bullish
  5. ROC 140.63Bullish
  6. ROC 251.55Bullish
  7. Stoch K40.53Neutral
  8. Stoch D40.71Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper30.60Neutral
  3. BB Middle30.03Neutral
  4. BB Lower29.46Neutral
  5. ATR0.65High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI22.83Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1029.92Bullish
  3. SMA 2029.85Bullish
  4. SMA 5029.00Bullish
  5. EMA 1029.91Bullish
  6. EMA 2029.71Bullish
  7. EMA 5029.33Bullish
  8. DEMA 1030.05Bullish
  9. DEMA 2030.12Bullish
  10. DEMA 5029.57Bullish
  11. TEMA 1029.95Bullish
  12. TEMA 2030.20Bearish
  13. TEMA 5029.96Bullish
  14. MACD0.29Bearish
  15. ADX30.90Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI58.10Neutral
  3. CCI46.79Neutral
  4. ROC 91.04Bullish
  5. ROC 142.72Bullish
  6. ROC 257.06Bullish
  7. Stoch K43.53Neutral
  8. Stoch D46.35Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper30.60Neutral
  3. BB Middle29.85Neutral
  4. BB Lower29.10Neutral
  5. ATR0.75Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI50.79Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1029.89Bullish
  3. SMA 2029.16Bullish
  4. SMA 5029.23Bullish
  5. EMA 1029.76Bullish
  6. EMA 2029.44Bullish
  7. EMA 5029.31Bullish
  8. DEMA 1030.18Bullish
  9. DEMA 2029.81Bullish
  10. DEMA 5029.25Bullish
  11. TEMA 1030.25Bearish
  12. TEMA 2030.20Bearish
  13. TEMA 50N/AN/A
  14. MACD0.33Bullish
  15. ADX17.14Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI59.44Neutral
  3. CCI80.05Neutral
  4. ROC 92.06Bullish
  5. ROC 147.44Bullish
  6. ROC 256.12Bullish
  7. Stoch K75.08Neutral
  8. Stoch D73.00Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper30.82Neutral
  3. BB Middle29.16Neutral
  4. BB Lower27.51Neutral
  5. ATR1.03Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI59.61Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1029.05Bullish
  3. SMA 2028.89Bullish
  4. SMA 5029.47Bullish
  5. SMA 10031.10Bearish
  6. SMA 20042.44Bearish
  7. EMA 1029.37Bullish
  8. EMA 2029.23Bullish
  9. EMA 5029.73Bullish
  10. EMA 10032.78Bearish
  11. EMA 20042.96Bearish
  12. DEMA 1029.74Bullish
  13. DEMA 2029.21Bullish
  14. DEMA 5028.16Bullish
  15. DEMA 10024.31Bullish
  16. DEMA 20022.14Bullish
  17. TEMA 1030.13Bearish
  18. TEMA 2029.49Bullish
  19. TEMA 5029.57Bullish
  20. TEMA 10027.85Bullish
  21. TEMA 20020.03Bullish
  22. MACD0.04Bullish
  23. ADX26.40Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI58.77Neutral
  3. CCI109.44Overbought
  4. ROC 144.05Bullish
  5. ROC 25-1.70Bearish
  6. Stoch K75.33Neutral
  7. Stoch D75.11Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper30.21Neutral
  3. BB Middle28.89Neutral
  4. BB Lower27.58Neutral
  5. ATR1.40Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI58.77Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2030.47Bearish
  3. SMA 5049.36Bearish
  4. EMA 2032.30Bearish
  5. EMA 5046.87Bearish
  6. DEMA 2024.71Bullish
  7. DEMA 5023.71Bullish
  8. TEMA 2027.86Bullish
  9. TEMA 5019.01Bullish
  10. MACD-5.15Bullish
  11. ADX24.81Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI36.04Neutral
  3. CCI-65.97Neutral
  4. ROC 14-12.65Bearish
  5. ROC 2517.37Bullish
  6. Stoch K22.16Neutral
  7. Stoch D27.05Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper34.56Neutral
  3. BB Middle30.47Neutral
  4. BB Lower26.37Neutral
  5. ATR3.85Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.00Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 629.70Bearish
  3. SMA 1248.90Bearish
  4. SMA 2476.64Bearish
  5. EMA 633.63Bearish
  6. EMA 1246.41Bearish
  7. EMA 2465.55Bearish
  8. DEMA 623.77Bullish
  9. DEMA 1224.01Bullish
  10. DEMA 2437.84Bearish
  11. TEMA 626.32Bullish
  12. TEMA 1219.62Bullish
  13. TEMA 2423.45Bullish
  14. MACD-22.56Bearish
  15. ADX20.33Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI38.32Neutral
  3. CCI-182.37Oversold
  4. ROC 25-71.76Bearish
  5. ROC 50-71.91Bearish
  6. Stoch K7.47Oversold
  7. Stoch D19.39Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper132.45Neutral
  3. BB Middle68.33Neutral
  4. BB Lower4.22Neutral
  5. ATR16.56Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI34.60Neutral